Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension
NCT02594917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2023-09-22
Summary
The investigators are performing this research study to determine whether having low iron-sulfur cluster levels can cause a disease known as pulmonary hypertension (PH). PH is defined as abnormally high blood pressure in the arteries of the lungs.
Usually, small specialized structures inside each human cell called mitochondria are in charge of generating energy within lung arteries for normal function. During situations of disease or stress, lung arteries undergo a change in the function of mitochondria, resulting in the development of PH. In studies on mice, investigators have learned that alterations in the production of specific metal complexes called iron-sulfur clusters are responsible for these changes. This makes it more likely that mice will develop PH.
In this study, the investigators want to find out if alteration of iron-sulfur cluster formation leads to increased likelihood of developing PH in humans.
Conditions
- Iron-sulfur Cluster Deficiency
- Pulmonary Hypertension
- Friedreich Ataxia
Interventions
- PROCEDURE
-
Right Heart Catheterization
Some participants (i.e., those that are willing and able) will undergo a Right Heart Catheterization to check Cardiopulmonary function.
- OTHER
-
Blood draw
Test and control group will be asked to give 20 ml of blood samples
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Stephen Chan, MD, PhD, FAHA · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2023-09-01
- Completion
- 2023-09-01
Countries
- United States
Study Locations
More Related Trials
-
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT01730092 ·Status: RECRUITING
-
The Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
NCT05250128 ·Status: UNKNOWN
-
Vascular Subphenotypes of Lung Disease in HIV & COPD
NCT01581086 ·Status: COMPLETED
-
Mechanisms of Familial Pulmonary Fibrosis
NCT03437486 ·Status: RECRUITING
-
Understanding Changes in Physical Function Using Principles of Precision Medicine
NCT05581082 ·Status: COMPLETED
-
Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment
NCT07254338 ·Status: RECRUITING
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
NCT00018408 ·Status: COMPLETED
-
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
NCT02055222 ·Status: COMPLETED
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
NCT00725309 ·Status: COMPLETED
-
Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis
NCT06521125 ·Status: NOT_YET_RECRUITING
-
Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects
NCT02886793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pulmonary Fibrosis and Telomerase Mutation Study
NCT01501578 ·Status: COMPLETED
-
Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
NCT06668051 ·Status: NOT_YET_RECRUITING
-
Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences
NCT06935825 ·Status: NOT_YET_RECRUITING
-
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
NCT00258544 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
NCT01484899 ·Status: COMPLETED
-
FIBRotic Interstitial Lung Disease and Nocturnal OXygen
NCT04586946 ·Status: COMPLETED
-
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
NCT01134822 ·Status: COMPLETED
-
Prevalence of Pompe's Disease in Respiratory Clinics
NCT02527239 ·Status: UNKNOWN
-
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02719184 ·Status: COMPLETED
-
Short Chain Fatty Acid Metabolism in COPD
NCT03327181 ·Status: COMPLETED ·Phase: NA